These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38012707)

  • 1. Disclosing the molecular profile of the human amniotic mesenchymal stromal cell secretome by filter-aided sample preparation proteomic characterization.
    Muntiu A; Papait A; Vincenzoni F; Vitali A; Lattanzi W; Romele P; Cargnoni A; Silini A; Parolini O; Desiderio C
    Stem Cell Res Ther; 2023 Nov; 14(1):339. PubMed ID: 38012707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native characterization and QC profiling of human amniotic mesenchymal stromal cell vesicular fractions for secretome-based therapy.
    Marassi V; La Rocca G; Placci A; Muntiu A; Vincenzoni F; Vitali A; Desiderio C; Maraldi T; Beretti F; Russo E; Miceli V; Conaldi PG; Papait A; Romele P; Cargnoni A; Silini AR; Alviano F; Parolini O; Giordani S; Zattoni A; Reschiglian P; Roda B
    Talanta; 2024 Aug; 276():126216. PubMed ID: 38761653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective.
    Papait A; Ragni E; Cargnoni A; Vertua E; Romele P; Masserdotti A; Perucca Orfei C; Signoroni PB; Magatti M; Silini AR; De Girolamo L; Parolini O
    Front Immunol; 2022; 13():960909. PubMed ID: 36052081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.
    Ragni E; Papait A; Perucca Orfei C; Silini AR; Colombini A; Viganò M; Libonati F; Parolini O; de Girolamo L
    Stem Cells Transl Med; 2021 Jul; 10(7):1044-1062. PubMed ID: 33656805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.
    Calligaris M; Zito G; Busà R; Bulati M; Iannolo G; Gallo A; Carreca AP; Cuscino N; Castelbuono S; Carcione C; Centi C; Amico G; Bertani A; Chinnici CM; Conaldi PG; Scilabra SD; Miceli V
    Front Cell Dev Biol; 2024; 12():1385712. PubMed ID: 38882056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human amniotic mesenchymal stromal cells promote bone regeneration via activating endogenous regeneration.
    Jiang F; Zhang W; Zhou M; Zhou Z; Shen M; Chen N; Jiang X
    Theranostics; 2020; 10(14):6216-6230. PubMed ID: 32483449
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy.
    Bilic G; Zeisberger SM; Mallik AS; Zimmermann R; Zisch AH
    Cell Transplant; 2008; 17(8):955-68. PubMed ID: 19069637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells: insights into the secretome.
    Makridakis M; Roubelakis MG; Vlahou A
    Biochim Biophys Acta; 2013 Nov; 1834(11):2380-4. PubMed ID: 23376432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway.
    Li JY; Ren KK; Zhang WJ; Xiao L; Wu HY; Liu QY; Ding T; Zhang XC; Nie WJ; Ke Y; Deng KY; Liu QW; Xin HB
    Stem Cell Res Ther; 2019 Aug; 10(1):247. PubMed ID: 31399039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation.
    Abbasi-Kangevari M; Ghamari SH; Safaeinejad F; Bahrami S; Niknejad H
    Front Immunol; 2019; 10():238. PubMed ID: 30842772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of autophagy and cell death induction in Panc1 pancreatic cancer by secretome of hAMSCs through downregulation of p-AKT/p-mTOR and upregulation of p-AMPK/ULK1 signal transduction pathways.
    Safari F; Dadvar F
    Tissue Cell; 2023 Oct; 84():102160. PubMed ID: 37482027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome.
    Lobov AA; Yudintceva NM; Mittenberg AG; Shabelnikov SV; Mikhailova NA; Malashicheva AB; Khotin MG
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the proliferation, migration and angiogenic properties of human amniotic epithelial and mesenchymal stem cells and their effects on endothelial cells.
    Wu Q; Fang T; Lang H; Chen M; Shi P; Pang X; Qi G
    Int J Mol Med; 2017 Apr; 39(4):918-926. PubMed ID: 28259958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological and Differentiation Properties of Amniotic Cells Are Retained After Immobilization in Pectin Gel.
    Silini AR; Spoldi V; De Munari S; Vertua E; Munarin F; Petrini P; Farè S; Parolini O
    Cell Transplant; 2018 Jan; 27(1):70-76. PubMed ID: 29562782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response.
    Wei X; Sun G; Zhao X; Wu Q; Chen L; Xu Y; Pang X; Qi G
    Int J Mol Med; 2019 Oct; 44(4):1425-1435. PubMed ID: 31364743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1/S phase.
    Rahimi Lifshagerd M; Safari F
    Clin Transl Oncol; 2023 Jun; 25(6):1702-1709. PubMed ID: 36617361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells.
    Ge X; Wang IN; Toma I; Sebastiano V; Liu J; Butte MJ; Reijo Pera RA; Yang PC
    Stem Cells Dev; 2012 Oct; 21(15):2798-808. PubMed ID: 22530853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice.
    Liu QW; Ying YM; Zhou JX; Zhang WJ; Liu ZX; Jia BB; Gu HC; Zhao CY; Guan XH; Deng KY; Xin HB
    Stem Cell Res Ther; 2022 Jun; 13(1):224. PubMed ID: 35659360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic techniques for characterisation of mesenchymal stem cell secretome.
    Kupcova Skalnikova H
    Biochimie; 2013 Dec; 95(12):2196-211. PubMed ID: 23880644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.